Pharmaceutical patent law: the Canadian perspective

被引:1
|
作者
Aumand, Livia [1 ]
Norman, John [1 ]
机构
[1] Gowling WLG Canada LLP, 160 Elgin St Suite 2600, Ottawa, ON K2P 1C3, Canada
关键词
biologics; Canada; drugs; generic; infringement; innovators; pharmaceuticals; validity;
D O I
10.4155/ppa-2016-0007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article provides an overview of the patent regime in Canada, with a focus on issues most relevant to the pharmaceutical industry. The process of applying for a patent is discussed, as well as enforcement and litigation. Recent developments in the case law dealing with patentability requirements - novelty, obviousness, utility and sufficiency - are reviewed. Finally, the impact of recently negotiated trade agreements on Canadian patent law is addressed. In this article, we aim to provide an overview of the patent regime in Canada, with a focus on issues that are particularly relevant to the pharmaceutical industry.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 50 条